HomeOLMA • NASDAQ
add
Olema Pharmaceuticals Inc
Previous close
$4.21
Day range
$4.06 - $4.31
Year range
$2.86 - $16.62
Market cap
291.10M USD
Avg Volume
1.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 36.77M | 10.69% |
Net income | -33.57M | -25.38% |
Net profit margin | — | — |
Earnings per share | -0.51 | -4.08% |
EBITDA | -36.65M | -10.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 434.09M | 65.80% |
Total assets | 450.98M | 62.84% |
Total liabilities | 42.02M | 82.28% |
Total equity | 408.96M | — |
Shares outstanding | 68.33M | — |
Price to book | 0.77 | — |
Return on assets | -26.99% | — |
Return on capital | -30.09% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -33.57M | -25.38% |
Cash from operations | -26.28M | -42.26% |
Cash from investing | -114.42M | -270.12% |
Cash from financing | 244.30M | 46,611.28% |
Net change in cash | 103.59M | 311.98% |
Free cash flow | -6.67M | 35.39% |
About
Founded
2006
Headquarters
Website
Employees
96
